Surrozen, Inc./DE Increase (Decrease) in Prepaid Expense and Other Assets
Surrozen, Inc./DE (SRZN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $255.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $322.00K.
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$67.00K.
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $149.00K.
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $681.00K, a 114.15% increase year-over-year.
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for fiscal 2025 was $67.00K.
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.11M.
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$915.00K, a 1930.00% decline from fiscal 2022.
- Surrozen, Inc./DE increase (decrease) in prepaid expense and other assets for fiscal 2022 was $50.00K, a 97.82% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $255.00K 10-Q · filed 2026-08-06 | $404.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.08M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$67.00K 10-Q · filed 2026-05-06 | $82.00K derived: sum of 2 quarters · filed 2026-05-06 | $763.00K derived: sum of 3 quarters · filed 2026-05-06 | $305.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $830.00K derived: sum of 2 quarters · filed 2026-03-23 | $372.00K derived: sum of 3 quarters · filed 2026-08-06 | $67.00K 10-K · filed 2026-03-23 | ||
| 2025-09-30 | $681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $223.00K derived: sum of 2 quarters · filed 2026-08-06 | -$82.00K 10-Q · filed 2025-11-07 | -$334.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$763.00K 10-Q · filed 2026-08-06 | -$1.01M derived: sum of 3 quarters · filed 2026-08-06 | -$697.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$305.00K 10-Q · filed 2026-05-06 | -$557.00K derived: sum of 2 quarters · filed 2026-05-06 | -$239.00K derived: sum of 3 quarters · filed 2026-05-06 | -$1.08M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | -$252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $66.00K derived: sum of 2 quarters · filed 2026-03-23 | -$771.00K derived: sum of 3 quarters · filed 2026-03-23 | -$1.11M 10-K · filed 2026-03-23 | ||
| 2024-09-30 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$519.00K derived: sum of 2 quarters · filed 2025-11-07 | -$859.00K 10-Q · filed 2025-11-07 | -$819.00K derived: sum of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | -$837.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.18M 10-Q · filed 2025-08-08 | -$1.14M derived: sum of 3 quarters · filed 2025-08-08 | -$396.00K derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | -$340.00K 10-Q · filed 2025-05-09 | -$300.00K derived: sum of 2 quarters · filed 2025-05-09 | $441.00K derived: sum of 3 quarters · filed 2025-05-09 | -$663.00K derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2023-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $781.00K derived: sum of 2 quarters · filed 2025-03-31 | -$323.00K derived: sum of 3 quarters · filed 2025-03-31 | -$915.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $741.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$363.00K derived: sum of 2 quarters · filed 2024-11-06 | -$955.00K 10-Q · filed 2024-11-06 | -$1.79M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$1.70M 10-Q · filed 2024-08-12 | -$2.53M derived: sum of 3 quarters · filed 2024-08-12 | -$337.00K derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | -$592.00K 10-Q · filed 2024-05-08 | -$1.43M derived: sum of 2 quarters · filed 2024-05-08 | $767.00K derived: sum of 3 quarters · filed 2024-05-08 | -$268.00K derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | -$835.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $1.36M derived: sum of 2 quarters · filed 2024-04-10 | $324.00K derived: sum of 3 quarters · filed 2024-04-10 | $50.00K 10-K · filed 2024-04-10 | ||
| 2022-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.16M derived: sum of 2 quarters · filed 2023-11-08 | $885.00K 10-Q · filed 2023-11-08 | $388.00K derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.31M 10-Q · filed 2023-08-09 | -$1.81M derived: sum of 3 quarters · filed 2023-08-09 | $240.00K derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$274.00K 10-Q · filed 2023-05-10 | -$771.00K derived: sum of 2 quarters · filed 2023-05-10 | $1.27M derived: sum of 3 quarters · filed 2023-05-10 | $1.69M derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | -$497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.55M derived: sum of 2 quarters · filed 2023-03-31 | $1.97M derived: sum of 3 quarters · filed 2023-03-31 | $2.30M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.46M derived: sum of 2 quarters · filed 2022-11-14 | $2.79M 10-Q · filed 2022-11-14 | $3.13M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $747.00K 10-Q · filed 2022-08-11 | -$263.54K 10-Q · filed 2021-08-09 | $1.08M derived: sum of 3 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $328.00K 10-Q · filed 2022-05-11 | -$156.52K 10-Q · filed 2021-05-24 | $661.00K derived: sum of 2 quarters · filed 2022-05-11 | |||
| 2020-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $732.00K 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | $399.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |